Bavarian Nordic to acquire Vivotif and Vaxchora travel vaccines from Emergent BioSolutions

Raghuram Kadari- February 17, 2023 0

Bavarian Nordic A/S will acquire two oral vaccines from Emergent BioSolutions for a total consideration of up to $380 million, to strengthen its position in ... Read More

Emergent BioSolutions begins phase 3 trial of CHIKV VLP vaccine candidate

pallavi123- October 16, 2021 0

Emergent BioSolutions said that it has dosed the first participant in a phase 3 clinical trial of CHIKV VLP — the company’s single-dose chikungunya vaccine ... Read More

Everything you need to know about Chikungunya Causes, Symptoms, Prevention and Treatment

pharmanewsdaily- April 6, 2018 0

Chikungunya is a viral fever transmitted by mosquitoes and spreads in humans by the bite of Aedes mosquitoes infected with Chikungunya virus. In this post ... Read More